Expected to be in market 2021 as per the articles. That puts off a lot of investors who are too short sighted IMO. I don't really mind waiting I didn't pick CYP to make a few hundred % i picked it as I think it's a long term returns stock (or it gets bought out).
That's not to say we aren't going to see good returns before 2021, i'm expecting solid returns after Fuji decides what they want to do post GvHD results and Asthma phase 1 could bring another Fuji deal or other players. Asthma is massive.
Ann: Final Preclinical Asthma Study Confirms Efficacy, page-40
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.015(6.38%) |
Mkt cap ! $45.16M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 28.0¢ | 24.5¢ | $103.8K | 408.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 35587 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 7013 | 2 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |